4//SEC Filing
Dyrness Albert D. 4
Accession 0001493152-22-036313
CIK 0001106838other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:30 PM ET
Size
5.1 KB
Accession
0001493152-22-036313
Insider Transaction Report
Form 4
Dyrness Albert D.
Director
Transactions
- Award
Common Stock
2022-12-14+3,770→ 30,893 total
Footnotes (2)
- [F1]On December 14, 2022, the Reporting Person was granted 3,770 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2024.
- [F2]Includes unvested RSUs.
Documents
Issuer
Sonnet BioTherapeutics Holdings, Inc.
CIK 0001106838
Entity typeother
Related Parties
1- filerCIK 0001664801
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:30 PM ET
- Size
- 5.1 KB